RGS9-2 mRNA). Inset shows
being due to supersensitivity of dopamine receptors on subtype expresses enkephalin, whereas the other expresses substance P and dynorphin (Aizman et al., 2000; the denervated side. In contrast, apomorphine does not induce circling in a normal animal. Graybiel, 2000) . While the precise functional roles played by these two subtypes of neurons remain incompletely In the present study, HSV-RGS9-2 was injected on one side of the nucleus accumbens, and HSV-LacZ was understood, there is substantial evidence that both contribute to the locomotor-activating and rewarding acinjected on the other. Apomorphine challenge induced circling in the animals with a strong directional bias:
tions of psychostimulants (Graybiel, 2000; Self and Nestler, 1998) . We used a double-labeling in situ hybridanimals rotated in a direction toward the side of RGS9-2 overexpression ( Figure 1B) . These results suggest an ization protocol to study the distribution of RGS9-2 between these two subtypes of nucleus accumbens neuimbalance in dopaminergic neurotransmission, with the side overexpressing RGS9-2 being less responsive than rons. As shown in Figure 2 , RGS9-2 is present in a majority of both enkephalinϩ and substance Pϩ neuthe other. Overexpression of RGS9-1 induced a similar degree of circling, whereas animals injected with vehicle rons. In general, enkephalinϩ neurons express high levels of D2 receptors, whereas dynorphin/substance Pϩ showed minimal circling and no rotational bias. Similarly, little circling and no rotational bias was observed when neurons express high levels of D1 receptors (Aizman et al., 2000; Graybiel, 2000) . Consistent with these patterns RGS4, another RGS protein prevalent in striatum (Gold et al., 1997), was overexpressed unilaterally in nucleus of expression, double-labeling immunohistochemistry confirmed that a majority of D2ϩ neurons also express accumbens ( Figure 1B) .
To determine whether the effect of RGS9-2 on re-RGS9-2 (not shown). Together, these anatomical data indicate that while RGS9-2 is broadly expressed in nusponses to apomorphine was specific to a particular dopamine receptor subtype, we tested the effect of D1-cleus accumbens and dorsal striatum, it is heavily colocalized in neurons that express D2 receptors. This selective and D2-selective dopamine receptor agonists on circling behavior of animals unilaterally injected with complements the behavioral-pharmacological data to further indicate an association between RGS9-2 and HSV-RGS9-2 into nucleus accumbens, with HSV-LacZ again injected on the other side. Animals administered signaling via dopamine D2 receptors. quinpirole, a D2-selective agonist, showed similar rotational bias as seen for apomorphine ( Figure 1B) , alEnhanced Locomotor Responses to Psychostimulants though the total amount of circling was not as great in RGS9 Knockout Mice as for apomorphine. In contrast, animals administered To complement our studies of RGS9-2 overexpression SKF81297, a D1-selective agonist, showed no rotational in rats, we characterized locomotor responses to psybias, although the animals displayed a general increase chostimulants in RGS9 knockout mice. Consistent with in locomotor activity that was comparable to that seen the overexpression data in rats, we found that mice with quinpirole. The findings indicate that the effect of with a null mutation in the RGS9 gene show augmented RGS9-2 on dopaminergic neurotransmission was seleclocomotor activation in response to amphetamine (Figtive for the D2 receptor. Quinpirole and SKF81297 had ure 3A). This enhanced responsiveness was apparent similar effects in animals injected with HSV-RGS9-1, at lower doses of amphetamine (1-2 mg/kg), while a indicating that the unique C-terminal tail of RGS9-2 is higher dose (5 mg/kg) elicited similar responses in the not required for these behavioral effects. mutants and wild-type littermates. There was no difference between mutant and wild-type mice in baseline Inhibition of Cocaine-Induced Locomotor Activity locomotor activity throughout a 30 min habituation peupon Overexpression of RGS9-2 riod (not shown) or in response to saline injections (FigPsychostimulants, such as cocaine, induce locomotor  ure 3A) . Figures 3B and 3C show, respectively, that activity via actions on D2 and D1 dopamine receptors, RGS9 knockout mice also exhibit increased locomotor an action mediated in large part via the nucleus accumresponses to cocaine as well as to the direct dopamine bens. It was, therefore, of interest to study the effect of receptor agonist apomorphine. This enhanced behav-RGS9-2 overexpression in this brain region on locomoioral responsiveness to dopamine agonists in the RGS9 tor responses to cocaine. As shown in Figure 1C , bilatknockouts is consistent with enhanced biochemical reeral overexpression of RGS9-2 in nucleus accumbens sponsiveness as well. The highly selective D2 agonist had no effect on baseline locomotor activity but signifiquinelorane produced a 52% Ϯ 4% (n ϭ 4; p Ͻ 0.025 by cantly attenuated the ability of a moderate dose of cot test) greater inhibition of forskolin-stimulated adenylyl caine (10 mg/kg i.p.) to stimulate locomotion in these cyclase activity in striatal extracts from RGS9 knockout animals compared to control animals. This effect of mice compared to their wild-type littermate controls. RGS9-2 could be overcome by a higher dose of cocaine Repeated exposure to psychostimulants causes pro-(20 mg/kg), which induced similar levels of locomotor gressively greater locomotor activity, a phenomenon activity in animals injected with HSV-RGS9-2 or HSVcalled locomotor sensitization. To study locomotor senLacZ. sitization in RGS9 mutant mice, we repeatedly administered cocaine at a low dose (7.5 mg/kg). As shown in Figure 3D , this dose of cocaine, upon initial exposure, Cellular Localization of RGS9-2 in Nucleus Accumbens The nucleus accumbens, like the striatum as a whole, caused relatively small increases in locomotor activity that were indistinguishable between RGS9 knockout contains two major subtypes of medium spiny projection neurons, which together comprise 90%-95% of the neumice and their wild-type littermates. Repeated cocaine administration produced significant locomotor sensitirons in this region. These neuronal subtypes can be differentiated by the neuropeptide they express; one zation in both wild-type and RGS9 mutant mice (locomo- . These binding studies wild-type and RGS9 knockout mice showed no baseline showed that there was no difference in the level of expreference for either side of the test chambers prior to pression of D1 or D2 receptors between wild-type and cocaine administration, and both developed significant knockout mice (Table 1) . place conditioning after training with cocaine ( Figure  3E) . Notably, the RSG9 mutants showed more than douIncreased RGS9 Expression in Brain by Chronic ble the degree of place conditioning compared to their Cocaine Administration wild-type littermates to a moderate dose of cocaine (10 To further characterize a possible role for RGS9-2 in mg/kg), with no apparent difference observed at a higher mediating responses to psychostimulants, we examined dose (15 mg/kg). Mice heterozygote for the RGS9 delethe ability of cocaine to alter levels of RGS9-2 expression tion showed intermediate place conditioning to cocaine in striatum. Levels of RGS9 immunoreactivity were ana-(not shown). These results indicate greater sensitivity to lyzed by Western blotting, using a polyclonal anti-RGS9 the rewarding effects of cocaine, as seen for locomotor antibody, which detects a protein band (76 kDa) that effects of the drug, in the absence of the RGS9 gene.
corresponds to the calculated size of RGS9-2, is striatalenriched, and is absent in striatal extracts from RGS9 Normal Dopamine Receptor Levels in RGS9 null mice. Chronic administration of cocaine for 7 days Null Mice produced a small, but statistically significant, increase Given the influence of RGS9-2 on dopamine signaling in the nucleus accumbens, it was important to determine in levels of RGS9-2 immunoreactivity in the nucleus ac- cumbens as well as in the dorsal striatum ( Figure 4A ). This effect required repeated cocaine administration, accumbens and dorsal striatum, respectively; n ϭ 7). In addition, chronic cocaine administration did not alter 5A and 5B) . Coexpression of RGS9-2 significantly accelerated both the on-and off-kinetics of D2 responses but had no effect on the amplitude of the current. This is similar to the effect of RGS9-2 and other RGS proteins on several G protein-coupled receptors (Kovoor et al., 2000) . To examine the effect of G␤5 on RGS9-2 function, we repeated the above experiment after reducing the amount of RGS9-2 cRNA injected per oocyte (from 10 ng to 5 ng). At this level of RGS9-2 cRNA, the deactivation rate was not significantly different from control. However, we found that coexpression of G␤5 with RGS9-2 significantly accelerated the speed of GIRK deactivation when compared to RGS9-2 alone ( Figure  5C , p Ͻ 0.05). Expression of G␤5 in the absence of RGS9-2 had no effect on GIRK kinetics (not shown), indicating the G␤5 functions to enhance the action of RGS9-2 on dopamine receptor-elicited GIRK kinetics. Thus, RGS9-2 and G␤5 appear to modulate dopamine receptor-GIRK signaling in a manner that is equivalent to the way they affect m2 muscarinic acetylcholine re- donor. Therefore, comparisons between different experimental groups are always made using oocytes from the same donor. RGS proteins consistently accelerate the failed to alter RGS9-2 mRNA levels (not shown). Cocaine deactivation kinetics of receptor-GIRK coupling across regulation of RGS9-2 showed some specificity for this donors, although the mean deactivation rates of the protein, since no effect was observed on two related RGS-expressing oocyte groups may be significantly dif-RGS proteins expressed in striatum, RGS7 or RGS11, ferent from donor to donor. or on the G protein subunit, G␤5 ( Figure 4B ). This subunit is of particular interest, because it has been reported Discussion to uniquely associate with RGS9-1 in retina (Kovoor et al., 2000; Martemyanov and Arshavsky, 2002; Nair et al.,
The highly enriched expression of RGS9-2 in striatum 2002), although a specific association with RGS9-2 has and the prevalence of dopamine neuromodulation in this yet to be established. structure suggest that RGS9-2 could serve specialized functions for striatal neurons and modulate signaling through dopamine receptors. We have tested this hyEffect of RGS9-2 on Kinetics of Dopamine D2 Receptor Signaling pothesis in vivo, using several well-established behavioral paradigms for dopamine function. Our results We used dopamine-evoked currents, mediated by inwardly rectifying K ϩ channels (GIRKs), recorded from indicate that overexpression of RGS9-2 diminishes sensitivity to the behavioral effects of dopamine agonists, Xenopus oocytes coexpressing functional Kir3.1/Kir3.2 channel heteromultimers along with the dopamine D2 while loss of RGS9 has the opposite effect. These actions of RGS9-2 seem most related to the D2 class of receptor to study the direct influence of RGS9-2 on D2 receptor signaling. Regulation of GIRK channels is one dopamine receptor, which is not surprising since the D2 receptor signals via Gi are known to be influenced by mechanism by which D2 receptors produce physiologi-RGS proteins, while the D1 receptor signals via Gs are known to be insensitive to most RGS proteins. Importantly, loss of RGS9-2 increases an animal's sensitivity to the behavioral effects of cocaine, whereas overexpression of RGS9-2 has the opposite effect. Moreover, chronic administration of cocaine increases levels of RGS9-2 in striatum. Together, these results suggest a role for RGS9-2 in mediating some of the functional changes in dopamine signaling induced in striatum after chronic cocaine exposure.
Circling behavior or rotation in rodents has been used for more than 30 years as a model system in which to study dopaminergic function in the basal ganglia. A functional imbalance in the dopaminergic system between the two sides of the brain, followed by administration of a dopamine agonist, results in circling: it is interpreted that the animal turns away from the side of higher dopaminergic activity. For example, upon unilateral lesioning of dopamine neurons with 6-hydroxydopamine (a dopaminergic neurotoxin), animals turn away from the lesioned side when challenged with apomorphine, a D1/D2 mixed receptor agonist (Ungersted and Arbuthnott, 1970). This circling is thought to be caused by greater sensitivity of striatal neurons on the lesioned side to dopamine stimulation, although the mechanism underlying this functional supersensitivity has remained unknown (Schwarting and Huston, 1996) .
In the present study, we used this established and highly reproducible behavioral response to dopaminergic agents to test the hypothesis that RGS9-2 may alter dopaminergic neurotransmission in striatum. Unilateral injections of HSV-RGS9-2 into the nucleus accumbens caused circling behavior to apomorphine. This is a striking finding, because apomorphine does not induce circling in a normal animal, and only dramatic manipulations (such as unilateral lesions of the dopamine system) have previously been shown to induce circling behavior. 
2000]).
(C) Control (Con) oocytes were prepared as described for (A) and Further evidence for a functional connection between (B). The other oocyte groups were injected in addition with RGS9-2 cRNA (5 ng) alone or RGS9-2 cRNA (5 ng) and G␤5 cRNA (10 ng). Jan, 1998; Kovoor and Lester, 2002). Coexpression of RGS9-2 accelerated both the on-and off-kinetics of self-administration of the drug. This effect was specific for RGS9-2, since no change was observed in levels of D2-mediated channel activation but did not alter the amplitude of the current. One of these effects, the accel-G␤5 or of RGS subtypes (RGS7, RGS11), which belong to the same subfamily of RGS proteins as RGS9-2. Ineration of deactivation kinetics, is consistent with the classical concept that RGS proteins stimulate the creased levels of RGS9-2, based on our in vivo behavioral data, would be expected to diminish D2 signaling. GTPase activity of the G␣i subunits through which D2 Hence, the upregulation of RGS9-2 by cocaine could receptors signal (Dohlman and Thorner, 1997; Berman represent a homeostatic response of D2 receptor-conand Gilman, 1998; De Vries et al., 2000) . To some extent, taining striatal neurons to excessive dopaminergic the increased rate constant for activation also derives transmission. This adaptation would therefore be exfrom the fact that equilibrium is approached more rapidly pected to diminish the animal's subsequent responif channels close more quickly. However, that steadysiveness to cocaine. Reduced responsiveness or "tolerstate amplitudes show little or no decrease in the presance" to the behavioral effects of cocaine is seen in ence of RGS9-2 is a well-known paradox of RGS protein human addicts and is thought to contribute to escalating action ( 
RGS9-2 and D2 receptors was the finding that the two

tions. The dorsal striatum contributes to the locomotor effects
The results presented here further demonstrate that of the drugs, whereas the nucleus accumbens is inbehavioral plasticity to drugs of abuse can be linked to volved in both the locomotor and rewarding effects (Self specific proteins that modulate cellular responses to the and Nestler, 1998; Wise, 1998). These drugs act by indrugs (Nestler, 2001 ). Thus, RGS9-2 levels are increased creasing dopaminergic transmission in striatal regions, in striatum by chronic exposure to cocaine, and modueither by inhibiting dopamine reuptake (cocaine) or stimlating RGS9-2 levels in animals alters their behavioral ulating dopamine release (amphetamine). The precise responses to cocaine. Together, these results establish contribution of D1 and D2 receptor subtypes in mediata functional interaction between RGS9-2 and drugs of ing these responses remains unclear, although both reabuse and contribute toward a more complete underceptors are clearly involved  standing of the molecular and cellular mechanisms by Wise, 1998; Self et al., 1998). Our results would suggest which repeated cocaine exposure causes a state of adthat RGS9-2 selectively modulates responses mediated diction. via the D2 receptor.
We also found that chronic, but not acute, administra-
Experimental Procedures
tion of cocaine increases levels of RGS9-2 immunoreactivity in the nucleus accumbens and dorsal striatum. For mice, locomotor activity was determined in an automated system in which the activity chambers were plastic cages (12 ϫ weeks old; see below) were used in these studies. All mice were bred from heterozygous crossings (mixed 129-B6 background); male and 18 ϫ 33 cm) with 10 pairs of photocell beams dividing the chamber into 11 rectangular fields, as described previously (Hiroi et al., 1997). female homozygous null mice and their wild-type littermates were used. There was no apparent gender difference in subsequent beMice were tested at the same time each day by an experimenter who did not know the genotype of the mice. For acute experiments, havioral analyses. Mice were housed by litter and not by genotype. The animal colony was climate controlled and kept on a 12 hr light/ animals were habituated to the chambers for 30 min, after which time they received i.p. injections of saline or of varying doses of dark cycle. Animals were group housed; food and water was made available ad libitum. amphetamine, cocaine, or apomorphine, and locomotor activity was assessed for an additional 30 min. For chronic experiments, animals were placed in the chambers immediately after an i.p. saline injection Generation and Use of HSV Constructs on the first 3 days (S1-S3). Horizontal activity was then measured HSV vectors containing RGS9-2, RGS9-1, RGS4, and LacZ were for 10 min. On days 4-8 (C1-C5), animals were given cocaine (7.5 prepared as described (Neve et al., 1997) . The average titer of the mg/kg i.p.) and activity was measured for 10 min. The short time purified virus stocks was Ͼ10 between) of the place conditioning apparatus freely for 20 min. Intracranial surgery was performed, using a 26 gauge hamilton Neither mutant mice nor their wild-type littermates showed a bias syringe, exactly as described (Carlezon et al., 1997) . The following to either of the two large chambers. The following three sessions coordinates were used for nucleus accumbens: anteroposterior, were used for conditioning: mice were alternatively confined to ei-Ϫ1.8 mm posterior to bregma; lateral/medial, ϩ2.5 mm from midline; ther of the two large chambers immediately after administration of and dorsal/ventral, Ϫ6.8 mm below dura; the injection syringe was cocaine (10 mg/kg i.p.) or saline for 20 min. On the fifth session, the angled at 10Њ from the midline. The syringe was left in place for 5 mice were placed in the central chamber and were allowed to move min before injection.
freely among the three chambers for 20 min. The time they spent in the cocaine-paired chamber minus that in the saline-paired chamber Rotation Behavior in Rats provides a measure of place conditioning. Animals were injected unilaterally with an HSV vector into the nucleus accumbens. HSV-LacZ was injected on the other side of the Cocaine Self-Administration brain as a control. Three and four days after surgery, when transgene Cocaine self-administration was carried out according to published expression is maximal, animals were given apomorphine (1 mg/kg procedures . Briefly, male Sprague-Dawley rats s.c.), quinpirole (1 mg/kg i.p.), or SKF-81297 (3 mg/kg s.c.) and weighing 300-325 g were randomized into two groups (saline and placed in a large (16 in diameter) round chamber for a period of cocaine) and trained to respond for saline or cocaine infusions in 40 min after drug administration. All rotations were recorded on 15 daily 4 hr test sessions (5-6 days/week). Animals were killed videotape and the net rotation asymmetry was calculated. At the 16-20 hr after the last self-administration session and the brains time of scoring the behavior, the researcher was blind to the orientawere rapidly dissected in ice-cold artificial CSF. tion (side of brain) of the HSV injections. All animals were pretested with apomorphine (1 mg/kg) for 3 days (each with a day interval
In Situ Hybridization and Immunohistochemistry between); animals that showed no directional bias and a robust Isotopic in situ hybridization for localization of HSV-RGS9-2 overexlocomotor response were used for the HSV injections; more than pression in brain was performed exactly as described (Gold et al., 80% of all pretested animals were used for subsequent experiments. 1997). For double-labeling flourescent in situ hybridization, rat brains Data were calculated as percentage of total turns away from HSVwere rapidly frozen on dry ice and stored at Ϫ80ЊC. Coronal 14 m LacZ and expressed as mean percentages; data from days 3 and sections through striatum ‫6.1ف(‬ to 0.9 mm rostral to bregma) were 4, which were indistinguishable, were combined. After testing, rats cryosectioned and thaw-mounted onto Superfrost Plus glass slides were perfused with paraformaldehyde, and the brains analyzed by (Fisher, Pittsburgh, PA). Sections were pretreated by fixation in Nissl to confirm the placement of the injection needle and the lack ice-cold 4% paraformaldehyde (20 min), dehydrated in increasing of toxicity. Some sections were examined for expression of RGS9-2 concentrations of ethanol, and allowed to air dry. Sections were by in situ hybridization or ␤-galactosidase by rehydrated, acetylated for 5 min, dehydrated, and air-dried as beimmunohistochemistry (Carlezon et al., 1997) .
fore, hybridized coverslipped in buffer containing 50% formamide, 5ϫ SSC, 5ϫ Denhardts, 250 g/ml yeast RNA, 0.5 mg/ml salmon testes DNA, 200-300 ng/ml RNA probe overnight at 65ЊC, in a humidLocomotor Activity Assays For rats, spontaneous locomotor activity was monitored in a circular ified chamber. Slides were washed to a stringency of 0.2ϫ SSC at 65ЊC and then blocked with 5% normal rabbit IgG and 1% blocking corridor (10 cm wide and 60 cm in diameter with walls 30 cm high; Med Associates Inc., St Albans, VT). Four photoelectric cells located reagent (Roche). Digoxigenin-labeled probes were detected first using a rabbit anti-digoxigenin antibody coupled to horseradish perequidistantly around the walls of the circles detected an animal's horizontal ambulatory activity by way of beam interruptions. Data oxidase (1:200: DAKO). The signal was amplified and detected using tyramide signal amplification; TSA-direct by deposition of Floureswere recorded via a PC equipped with a customized software (Med Associates). Separate groups of animals were tested with 10 mg/kg cein (Perkin-Elmer). The HRP conjugated to the anti-digoxigenin antibody was quenched by H 2 O 2 treatment (3%, 15 min), and the (n ϭ 6 per group) and 20 mg/kg (n ϭ 12 per group) cocaine. Animals were randomized into treatment groups (HSV-LacZ and HSV-RGS9-biotin-labeled probes were detected with 1:1000 streptavidin conjugated to HRP (Perkin-Elmer) followed by amplification with TSA-2) and habituated to the locomotor apparatus for 2 hr. On the next day, animals received HSV vectors in the nucleus accumbens shell direct deposition of Cy3 (Perkin-Elmer). The slides were then dehydrated and mounted in DPX (Fluka). Biotinylated and digoxigeninon a stereotaxic frame. Following 2 days of recovery, animals were tested with cocaine on locomotor activity for 2 hr. Data were analabeled antisense riboprobes complementary to RGS9-2, enkepha-lin, or substance P were transcribed in vitro using digoxigenin and MgCl 2 , 1 mM CaCl 2 , and 5 mM HEPES [pH 7.5]) solution supplemented with sodiumpyruvate (2.5 mM) and gentamycin (50 g/ml). biotin in vitro transcription kits (Roche). All three transcripts localized by FISH in these experiments are striatally abundant mRNAs with All oocytes were injected with 1 ng of cRNA for the D2 receptor, and 0.02 ng of cRNA each for GIRK1 and GIRK2. Dopamine (1 relatively far lower mRNA concentrations in overlying neocortex. This regional labeling footprint was utilized to assess background M) was used as the dopamine receptor agonist. A valve system controlled by the data acquisition software pCLAMP 6 (Axon Instrulabeling. In all experiments, the digoxigenin-labeled riboprobes had very low background signal. The biotinylated-labeled riboprobes ments) was used to control solution changes and to minimize washing and washout times. Two-electrode voltage clamp recordings of had consistently higher background signal, but specific signal was easily distinguished by subtracting out the background as measured the oocytes were performed 36-72 hr after cRNA injection. Membrane potential was clamped at Ϫ80 mV using a Geneclamp 500 in neocortex. As an additional tool for assessing background labeling, all experiments included control conditions, where sections amplifier (Axon Instruments) and pCLAMP 6 software. Electrodes were filled with 3 M KCl and had resistances of 0.5-1.5 M⍀. To were mock-hybridized with no probe and then processed through the streptavidin-HRP-TSA amplification. To assess the degree of reveal inward currents through the inwardly rectifying GIRK channels, recordings were performed in oocyte saline buffer with ele-TSA-mediated crossamplification, single-labeling controls for both haptens were included in each experiment. No significant differvated ( 
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